Quick Answer
Jazz Pharmaceuticals plc reported Stockholders Equity of $4.32 billion for fiscal year 2025.
Jazz Pharmaceuticals plc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.32B | +5.5% |
| 2024 | $4.09B | +9.5% |
| 2023 | $3.74B | +21.1% |
| 2022 | $3.09B | -22.2% |
| 2021 | $3.97B | +8.3% |
| 2020 | $3.66B | +17.6% |
| 2019 | $3.11B | +12.8% |
| 2018 | $2.76B | +1.6% |
| 2017 | $2.71B | +44.5% |
| 2016 | $1.88B | +17.4% |
| 2015 | $1.60B | +16.6% |
| 2014 | $1.37B | +5.8% |
| 2013 | $1.30B | +15.5% |
| 2012 | $1.12B | +481.6% |
| 2011 | $192.79M | +531.0% |
| 2010 | $30.55M | +141.9% |
| 2009 | -$72.83M | +21.6% |
| 2008 | -$92.88M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.96B | -5.1% | +6.8% |
| June 30, 2025 | $3.71B | -1.5% | -11.2% |
| March 31, 2025 | $4.17B | +12.9% | +2.0% |
| December 31, 2024 | $4.09B | +9.5% | -1.9% |
| September 30, 2024 | $4.17B | +19.5% | +10.9% |
| June 30, 2024 | $3.76B | +6.7% | +1.8% |
| March 31, 2024 | $3.70B | +10.8% | -1.1% |
| December 31, 2023 | $3.74B | +21.1% | +7.1% |
- Jazz Pharmaceuticals plc showed an increase of +5.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, Jazz Pharmaceuticals plc’s stockholders equity has grown by 4749.7% (from -$92.88 million to $4.32 billion).
- The most recent figure is from Jazz Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: